Printer Friendly


Galactosemia is a rare hereditary disease leading not only to cirrhosis in infants, but, more seriously, to early, devastating illness if not diagnosed quickly. This disease is caused by elevated levels of galactose (a sugar in milk) in the blood resulting from a deficiency of the liver enzyme required for its metabolism (breakdown).

To have the disease, a child must inherit the tendency from both parents. The incidence of the disease is approximately 1:20,000 live births. For each pregna ncy, in such a family, there is a 1 in 4 chance a baby will be born with the deficiency. Because of the potentially disastrous effects of late diagnosis man y states have mandatory neonatal screening programs for galactosemia.

The disease usually appears in the first few days of life following the ingestion of breast milk or formula. Vomiting, liver enlargement, and jaundice are often the earliest signs of the disease, but bacterial infections (often severe), irritability, failure to gain weight, and diarrhea may also occur. If unrecogni zed in the newborn period, the disease may produce liver, brain, eye and kidney damage.

Blood tests can make the diagnosis. The disease is detected by measuring the level of enzyme in red blood cells, white blood cells or liver. Affected patients have no enzyme activity; carriers (parents) have intermediate enzyme activity (about 1/2 the normal level). A galactose tolerance test should never be done, as it may be harmful. Affected infants who ingest galactose will excrete it in large quantities in their urine where it can also be detected. If the infant is vomiting, and not taking milk, the test can be negative. If the disease is suspected, the diagnosis should be confirmed by blood testing.

Treatment is based on elimination of galactose from the diet. This may be done in the early neonatal period by stopping breast feeding and by the administration of diets which contain no lactose or galactose, ([Nutramigen.sup. R], [Pregestimil.sup.R]). This diet should be compulsively followed, and continued for years, and possibly for life. The red blood cell levels of galactose or its metabolites (Galactose-1-phosphate) may be used as a monitor to gauge the adherence to the d iet and restriction of galactose. It is also recommended that mothers of affected infants be placed on a galactose-free diet during the subsequent pregnancy. This may somewhat modify symptoms present at birth. With early therapy, any liver damage which occurred in the first few days of life will nearly completely heal.

Galactosemia should be considered in any jaundiced infant because of beneficial effects of early dietary restriction.
COPYRIGHT 1991 American Liver Foundation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Pamphlet by: American Liver Foundation
Article Type:pamphlet
Date:Sep 23, 1991
Previous Article:Fatty liver.
Next Article:Gilbert's syndrome.

Related Articles
Genetic factor affecting dairy products linked to ovarian cancer.
Neonatal hepatitis.
Testing for Disorders at Birth.
Calendar of events. (what's happening).
Preventing maternal mortality.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters